Nektar to team with Bayer on inhaled antibiotic
August 08 2007
Nektar Therapeutics, co-marketer of the inhaled insulin Exubera, has inked a deal to jointly develop an inhaled antibiotic to treat ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.